Labiotech.eu

News and Trends 12 Mar 2018

We Can Now Make Plastics Out of Old Clothes Using Biology

Carbios, a French biotech, has developed an environmentally-friendly method to break down the PET plastic fibers in textile waste using enzymes. Carbios has developed a technology which can depolymerize textile waste fibers made of PET plastics into their original monomers. The technology uses enzymes to create biodegradable plastics and recycle existing plastics into their original compounds for […]

March 12, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 12 Mar 2018

A Flick of a Switch Can Cause Age-Related Brain Deterioration

Switching certain genes on or off causes the premature aging of stem cells that repair the brain. Identifying them could provide a target for new therapeutic approaches against neurodegenerative diseases. Scientists at the Babraham Insitute in Cambridge and the University of Sapienza in Rome have identified a number of genes involved in the aging of […]

March 12, 2018 - 3 minutesmins - By Alex Dale

Interview 12 Mar 2018

A Dutch Company on the Quest Against Cystic Fibrosis

ProQR is the result of a personal quest against cystic fibrosis started by its CEO, Daniel de Boer. Interested in his story and the company’s unique approach to treating the disease using RNA technology, I decided to speak with him. Daniel de Boer founded ProQR in 2012 following a strong determination to improve the lives […]

March 12, 2018 - 6 minutesmins - By Clara Rodríguez Fernández

Immenthep Multibacterial Infection Vaccine 2 min

Startup Scout 9 Mar 2018

This Portugese Biotech is Developing a Vaccine for Life-Threatening Multibacterial Infections

This week, we’re in Cantanhede, a small city near the coast in Portugal, to visit Immunethep. The company is developing immunotherapies against life-threatening multibacterial infections using a virulence mechanism common to different types of bacteria. Mission: Founded in 2014, Immunethep is a spin-off from the University of Porto that discovered a novel virulence mechanism by which bacteria suppress the […]

March 9, 2018 - 2 minutesmins - By Alexander Burik

evotec sanofi infectious disease pipeline

More News! 8 Mar 2018

Evotec Takes Over Sanofi’s Infectious Disease Pipeline

Evotec will be getting over 10 assets, €60M upfront and about 100 scientists from Sanofi’s infectious disease research unit to work on developing new antimicrobials. Evotec has entered exclusive negotiations with Sanofi to accelerate infectious disease R&D through a new innovation platform located near Lyon, France, that will be open to academia, private companies, foundations and government agencies. Sanofi, […]

March 8, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

bone therapeutics spinal fusion cell therapy

News and Trends 8 Mar 2018

Belgian Firm Raises €19M to Fix Spinal Fusion with Cell Therapy

Bone Therapeutics has raised €19.5M through a private placement that will fund the completion of clinical trials testing its cell therapy for spinal fusion and other bone diseases. Based in Groselies, Belgium, Bone Therapeutics wants to use cell therapy to help people with bone injuries or diseases regenerate healthy bone. In order to complete its […]

March 8, 2018 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 8 Mar 2018

French Biotech Targets Gut Microbiome to Treat Diabetes

Valbiotis has shown that its treatment restores diversity in a population of gut microorganisms imbalanced by type 2 diabetes in mice. Valbiotis, based in Périgny, France, wants to treat type 2 diabetes by restoring the balance of microbial populations in the gut microbiome. New data from a metagenomic sequencing study in mice has shown that its drug, […]

March 8, 2018 - 3 minutesmins - By Alexander Burik

Best in Biotech 8 Mar 2018

Say Hello to the Top 14 Entrepreneurial Women in European Biotech

Today, March 8, is international women’s day. To celebrate the achievements of women we’re revisiting our list of the women that have founded some of the hottest biotechs in Europe. Once upon a time, you would have been hard pushed to find a woman in a senior position at a top biotech – now, they […]

March 8, 2018 - 8 minutesmins - By Alex Dale

News and Trends 7 Mar 2018

This Spanish Biotech Might Have the First Effective Treatment for a Rare Blood Condition

Sanifit has successfully completed a Phase II trial with what could be the first effective treatment for calciphylaxis, a deadly rare disease caused by calcium accumulation in the blood. Mallorca-based Sanifit is targeting calciphylaxis with its treatment called SNF472. Results from Sanifit’s Phase II trial show that the drug promotes wound healing and reduces pain, though the details […]

March 7, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 7 Mar 2018

Oxford Keeps Growing as a Hotspot for Cancer Vaccines with New Fundraising

Oxford Vacmedix has secured $12.5M (€10M) to start its first clinical trials, joining other Oxford-based biotechs in the cancer vaccine field such as Vaccitech and SpyBiotech. Oxford Vacmedix has secured Series A financing to continue the development of its two lead cancer vaccines to target cervical cancer and other solid tumors. The financing round represents the […]

March 7, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 6 Mar 2018

Oxford Spin-out Moves Gene Therapy For Blindness Into Phase III Trial

Nightstar Therapeutics will begin the first Phase III trial for a gene therapy targeting choroideremia, a rare disorder leading to complete blindness. Nightstar will launch the first-ever Phase III trial testing a gene therapy for choroideremia, a genetic disorder characterized by night blindness and gradual loss of vision that eventually leads to complete blindness. The trial, STAR, […]

March 6, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 6 Mar 2018

Swiss VC Closes €86M Fund for Medical Biotech in Europe

BioMedPartners has raised CHF100M (€86M) that will be invested in medical biotech companies in Switzerland, Germany, and other EU countries. Swiss VC BioMedPartners has managed to gather some big European investors to close its third venture capital fund, called BioMedInvest III and sized at CHF 100M (€86M). Among the investors are the European Investment Fund […]

March 6, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

We Can Now Make Plastics Out of Old Clothes Using Biology

A Flick of a Switch Can Cause Age-Related Brain Deterioration

A Dutch Company on the Quest Against Cystic Fibrosis

This Portugese Biotech is Developing a Vaccine for Life-Threatening Multibacterial Infections

Evotec Takes Over Sanofi’s Infectious Disease Pipeline

Belgian Firm Raises €19M to Fix Spinal Fusion with Cell Therapy

French Biotech Targets Gut Microbiome to Treat Diabetes

Say Hello to the Top 14 Entrepreneurial Women in European Biotech

This Spanish Biotech Might Have the First Effective Treatment for a Rare Blood Condition

Oxford Keeps Growing as a Hotspot for Cancer Vaccines with New Fundraising

Oxford Spin-out Moves Gene Therapy For Blindness Into Phase III Trial

Swiss VC Closes €86M Fund for Medical Biotech in Europe

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!